Goldman Sachs on uniQure BV (QURE): 'we now expect a US approval in 2Q27 (vs. 2030 prior, assuming priority review...'
Tweet Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Neutral rating and $46.00 price target on uniQure BV (NASDAQ: QURE).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
